- Home
- ADVB vs MIRA Comparison
ADVB vs MIRA Comparison
Compare ADVB & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- MIRA
- Stock Information
- Founded
- ADVB 2014
- MIRA 2020
- Country
- ADVB United States
- MIRA United States
- Employees
- ADVB N/A
- MIRA N/A
- Industry
- ADVB Medical Specialities
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- MIRA Health Care
- Exchange
- ADVB Nasdaq
- MIRA Nasdaq
- Market Cap
- ADVB 20.8M
- MIRA 19.5M
- IPO Year
- ADVB 2025
- MIRA 2023
- Fundamental
- Price
- ADVB $0.70
- MIRA $1.24
- Analyst Decision
- ADVB
- MIRA Strong Buy
- Analyst Count
- ADVB 0
- MIRA 2
- Target Price
- ADVB N/A
- MIRA $14.00
- AVG Volume (30 Days)
- ADVB 146.2K
- MIRA 204.1K
- Earning Date
- ADVB 08-03-2025
- MIRA 08-12-2025
- Dividend Yield
- ADVB N/A
- MIRA N/A
- EPS Growth
- ADVB N/A
- MIRA N/A
- EPS
- ADVB N/A
- MIRA N/A
- Revenue
- ADVB N/A
- MIRA N/A
- Revenue This Year
- ADVB N/A
- MIRA N/A
- Revenue Next Year
- ADVB N/A
- MIRA N/A
- P/E Ratio
- ADVB N/A
- MIRA N/A
- Revenue Growth
- ADVB N/A
- MIRA N/A
- 52 Week Low
- ADVB $0.56
- MIRA $0.51
- 52 Week High
- ADVB $4.10
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- MIRA 49.62
- Support Level
- ADVB N/A
- MIRA $1.21
- Resistance Level
- ADVB N/A
- MIRA $1.26
- Average True Range (ATR)
- ADVB 0.00
- MIRA 0.07
- MACD
- ADVB 0.00
- MIRA -0.01
- Stochastic Oscillator
- ADVB 0.00
- MIRA 47.37
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.